AksharChem Q4 FY26 Results: Revenue ₹105.79 Cr

What AksharChem reported for March 2026

AksharChem (India) Ltd reported a stronger March 2026 quarter on the topline, with revenue rising to ₹105.79 crore. The company’s standalone net profit for the quarter came in at ₹4.84 crore, showing a sharp year-on-year jump from the March 2025 quarter. The results were reflected in the company’s reported standalone quarterly numbers, which also showed a rise in earnings per share (EPS) to ₹6.02 in March 2026 from ₹1.73 in March 2025. Even with the profit improvement, EBITDA fell year-on-year to ₹5.38 crore from ₹6.18 crore. The March 2026 quarter was notable because it followed a loss-making December 2025 quarter, based on the company’s unaudited disclosures.

Key standalone metrics: Q4 FY25-26 (March 2026)

The reported “Q4 FY25-26” snapshot dated May 21, 2026 showed revenue of 105 (₹ crore) with QoQ growth of 31.62% and YoY growth of 16.59%. The same snapshot listed gross profit of 1 (₹ crore), with QoQ at -184.92% and YoY at -60.95%. Net profit was listed at 4 (₹ crore), with QoQ at -204.77% and YoY at 250.00%. In the detailed quarterly results section, net sales were specified at ₹105.79 crore in March 2026, up 16.58% from ₹90.74 crore in March 2025. Quarterly net profit was reported at ₹4.84 crore in March 2026, up 248.57% from ₹1.39 crore in March 2025. EBITDA was reported at ₹5.38 crore, down 12.94% from ₹6.18 crore a year earlier.

Quarter-on-quarter swing after December 2025 losses

Quarterly numbers provided for period-end dates show a sharp turnaround from December 2025 to March 2026. Total revenue for Dec 2025 was reported at ₹80.38 crore, moving up to ₹105.79 crore in Mar 2026. Net income in Dec 2025 was reported at -₹4.62 crore, compared with ₹4.84 crore in Mar 2026. The same dataset showed diluted normalized EPS at -₹5.75 for Dec 2025 and ₹6.02 for Mar 2026. This sequence indicates that the March 2026 quarter reversed losses seen in the immediately preceding quarters. At the same time, the gross profit figure in the Q4 FY25-26 snapshot was weak and showed large negative percentage changes versus the earlier period.

How revenue and operating profit trended across quarters

A longer quarterly trend table (Jun 2023 to Mar 2026) shows revenue moving in a range before the March 2026 jump. Revenue (₹ crore) was listed at 72 in Jun 2023, rising to 82 by Mar 2024 and then 91 by Mar 2025. It then moved through 97 in Jun 2025, 89 in Sep 2025, 80 in Dec 2025, and climbed to 106 in Mar 2026 in that series. On profitability, operating profit in that same table improved from negative numbers in mid-2023 to positive territory in later quarters. Operating profit was shown at -1 (₹ crore) in Jun 2023, -3 in Sep 2023, then 5 in Dec 2023, and around 6 for multiple quarters through Jun 2025. It softened to 2 in Sep 2025, 3 in Dec 2025, and 5 in Mar 2026, with operating margin (OPM) at 5.0% for Mar 2026.

December 2025 board meeting and unaudited results

AksharChem held its board meeting on January 28, 2026 to announce unaudited financial results for the quarter and nine months ended December 31, 2025. The board approved the financial performance figures along with the Limited Review Report from the statutory auditors. For the quarter ended December 31, 2025, the company’s total income was stated at ₹1,023.10 million, which converts to ₹102.31 crore. This was reported as a 14.50% increase over ₹893.53 million (₹89.35 crore) in the previous quarter on a QoQ basis. On a year-on-year basis, total income rose 27.56% from ₹802.04 million (₹80.20 crore). Despite higher total income, the company reported a net loss of ₹7.42 million (₹0.74 crore) for the quarter.

Net loss comparison: QoQ improvement but YoY decline in December 2025

The December 2025 quarter’s net loss of ₹0.74 crore was described as a 45.83% improvement compared to a loss of ₹13.70 million (₹1.37 crore) in the previous quarter. However, the same comparison noted a sharp turnaround versus the corresponding quarter of the prior year, when the company had reported a net profit of ₹11.89 million (₹1.19 crore). In addition, a separate earnings note summarised unaudited Q3 FY2025 and nine-month results, stating quarterly revenue of ₹8,038 lakhs (₹80.38 crore) and nine-month total income of ₹26,676 lakhs (₹266.76 crore). These numbers align with the Dec 2025 revenue level shown in the period-end table. Put together, the disclosures show that revenue growth did not automatically translate into quarterly profitability during that period. The March 2026 profit print therefore stands out after a stretch of reported losses.

First quarter FY2026 snapshot: revenue up, margin lower

For the quarter ended June 30, 2025, AksharChem reported revenue of ₹970.0 million, which converts to ₹97.0 crore, up 13% from 1Q 2025. Net income for that quarter was ₹7.11 million, or ₹0.71 crore, down 38% from 1Q 2025. The company’s profit margin was stated at 0.7%, down from 1.3% in 1Q 2025, with the decrease attributed to higher expenses. EPS for the quarter was ₹0.89, compared with ₹1.43 in 1Q 2025. Another standalone comparison table showed total income of ₹96.9987 crore in Q1 FY2026 versus ₹90.6462 crore in Q4 FY2025, while net profit reduced to ₹0.7110 crore from ₹1.3871 crore and EPS fell to ₹0.89 from ₹1.73.

Market context: stock price move cited in the data

A price snapshot in the provided data showed AksharChem at 226.85, up 37.80 or 19.99%, updated on 03 Jun 2026. No additional context on the driver of this move was included alongside the price line. The timing is close to the May 21, 2026 date referenced for the March 2026 quarter snapshot, which investors often track around earnings season. However, the dataset itself only provides the price change and update date, without linking it to any specific announcement. Investors typically interpret such moves alongside revenue, profit, and margin trends visible in quarterly series. In AksharChem’s case, the March 2026 quarter combined higher revenue with a return to net profit.

Why the March 2026 quarter matters for tracking performance

The key point in the numbers is the sharp swing from losses in Sep 2025 and Dec 2025 to a positive net income in Mar 2026. Revenue recovered strongly from ₹80.38 crore in Dec 2025 to ₹105.79 crore in Mar 2026, based on the period-end table. EPS also moved from negative territory to ₹6.02 in the same transition. At the same time, EBITDA was lower year-on-year in Mar 2026, showing that profit improvement and operating performance can diverge depending on cost structure and other line items. The longer quarterly trend table also shows operating margin peaking near 7% in mid-2024 and easing to 5% by Mar 2026. That mix of revenue growth and margin variability is central to how investors track specialty chemical companies quarter to quarter.

Conclusion

AksharChem’s March 2026 standalone results showed revenue of ₹105.79 crore and net profit of ₹4.84 crore, with EPS rising to ₹6.02. The quarter marked a turnaround from the loss-making December 2025 period, even as EBITDA fell year-on-year. The company had earlier approved unaudited results for the quarter and nine months ended December 31, 2025 at a board meeting held on January 28, 2026. Going forward, investors will likely watch whether revenue levels seen in March 2026 sustain and how margins behave relative to the swings visible across the FY2025-26 quarters.